Rafael Holdings, Inc. Class B
Key Metrics
- Previous Close
- $1.81
- 52-Week Range
- $1.12 – $3.96
- Market Cap
- $96.20M
- P/E (TTM)
- —
- EPS (TTM)
- -0.72
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- 1.28
- PEG Ratio
- —
- Return on Equity
- -37.59%
- Return on Assets
- -22.77%
- Gross Margin
- 95.10%
- Operating Margin
- -3837.99%
- Profit Margin
- 0.00%
- Current Ratio
- 3.16
- Debt/Equity
- 0.01
- Total Debt
- $610.00K
- Free Cash Flow
- $-20.67M
- Revenue Growth
- -50.60%
- Earnings Growth
- —
- Enterprise Value
- $71.73M
Market Snapshot
About
Rafael Holdings, Inc. Class B operates as a holding company with interests in pharmaceutical development and commercial real estate. The company supports clinical-stage biotech programs focused on cancer metabolism while maintaining income-producing real estate properties. Rafael provides capital and strategic support to its portfolio companies.